These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21557214)

  • 1. Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells.
    Vella S; Conti M; Tasso R; Cancedda R; Pagano A
    Int J Cancer; 2012 Apr; 130(7):1484-93. PubMed ID: 21557214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
    Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
    Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
    Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichloroacetate stimulates changes in the mitochondrial network morphology via partial mitophagy in human SH-SY5Y neuroblastoma cells.
    Pajuelo-Reguera D; Alán L; Olejár T; Ježek P
    Int J Oncol; 2015; 46(6):2409-18. PubMed ID: 25846762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirubin-3'-oxime induces mitochondrial dysfunction and triggers growth inhibition and cell cycle arrest in human neuroblastoma cells.
    Liao XM; Leung KN
    Oncol Rep; 2013 Jan; 29(1):371-9. PubMed ID: 23117445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
    Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
    Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
    Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity.
    Trapella C; Voltan R; Melloni E; Tisato V; Celeghini C; Bianco S; Fantinati A; Salvadori S; Guerrini R; Secchiero P; Zauli G
    J Med Chem; 2016 Jan; 59(1):147-56. PubMed ID: 26653539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
    Pathak RK; Marrache S; Harn DA; Dhar S
    ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells.
    Saha S; Ghosh M; Dutta SK
    Sci Rep; 2015 Jan; 5():7762. PubMed ID: 25585916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.
    Xie J; Wang BS; Yu DH; Lu Q; Ma J; Qi H; Fang C; Chen HZ
    Int J Oncol; 2011 Feb; 38(2):409-17. PubMed ID: 21132264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
    Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
    Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation.
    Zhou X; Chen R; Yu Z; Li R; Li J; Zhao X; Song S; Liu J; Huang G
    Mol Cancer; 2015 Mar; 14():63. PubMed ID: 25888721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
    Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
    Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetate.
    Hanberry BS; Berger R; Zastre JA
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):585-94. PubMed ID: 24452394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
    J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma.
    Pyaskovskaya ON; Boychuk IV; Fedorchuk AG; Kolesnik DL; Dasyukevich OI; Solyanik GI
    Exp Oncol; 2015 Sep; 37(3):192-6. PubMed ID: 26422103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.
    Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N
    Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.